Author(s)
Purpose
- Pathology:
Nervous system diseases
Psychiatry/psychology
- Disease:
Alzheimer Disease
- Objective:
To measure drug efficacy in Alzheimer's disease clinical trials
- Population for intended use:
Adult
Geriatrics
Characteristics
- Type of instrument:
Physical functioning
Psychological functioning (incl. coping)
- Administration mode:
Interviewer-administered
- Number of items:
Six tests, yielding a total of nine outcome measures
- Recall/Observation period:
None
Language(s)
- Original language:
English for the USA
- List of existing translations:
The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.
NTB
| Afrikaans | Dutch for the Netherlands* | Italian for Italy* | Slovak |
| Croatian | Finnish for Finland | Polish for Poland | Spanish for Spain* |
| Czech | French for France* | Portuguese for Portugal | Swedish for Sweden* |
| Danish for Denmark* | German for Germany* | Russian for Russia | |
| Dutch for Belgium (Flemish) | Hungarian | Serbian |
* Performed by the MAPI Institute
Bibliographic reference(s) of the original questionnaire
Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol. 2007 Sep;64(9):1323-9 (PubMed)
Last update: March 2012
Last update in collaboration with the author: January 2012
